{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:22:30Z","timestamp":1785115350082,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Platinum resistance is one of the most challenging problems in ovarian cancer treatment. High-throughput functional siRNA screening identified tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE-1) as a gene that confers cells resistant to cisplatin. Conversely enforced over-expression of TIE-1 was validated to decrease cisplatin sensitivity in multiple ovarian cancer cell lines and up-regulation of TIE-1 was correlated with poor prognosis and cisplatin resistance in patients with ovarian cancer. Mechanistically, TIE-1 up-regulates the nucleotide excision repair (NER) system mediated by xeroderma pigmentosum complementation group C (XPC), thereby leading to decreased susceptibility to cisplatin-induced cell death without affecting cisplatin uptake and excretion. Importantly potentiation of therapeutic efficacy by TIE-1 inhibition was selective to DNA-adduct-type chemotherapeutic platinum reagents. Therefore, TIE-1 is suggested to promote XPC-dependent NER, rendering ovarian cancer cells resistant to platinum. Accompanied with novel findings, TIE-1 could represent as a novel therapeutic target for platinum-resistant ovarian cancer.<\/jats:p>","DOI":"10.1038\/s41598-018-31069-2","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:04:56Z","timestamp":1535562296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Masumi","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hasegawa-Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Grandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-6135","authenticated-orcid":false,"given":"Kazuyuki","family":"Kitatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"31069_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359\u2013386, https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int J Cancer"},{"key":"31069_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal, R. & Kaye, S. B. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3, 502\u2013516, https:\/\/doi.org\/10.1038\/nrc1123 (2003).","journal-title":"Nat Rev Cancer"},{"key":"31069_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman, R. L., Monk, B. J., Sood, A. K. & Herzog, T. J. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol 10, 211\u2013224, https:\/\/doi.org\/10.1038\/nrclinonc.2013.5 (2013).","journal-title":"Nat Rev Clin Oncol"},{"key":"31069_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/onc.2014.136","volume":"34","author":"QH Miow","year":"2015","unstructured":"Miow, Q. H. et al. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene 34, 1899\u20131907, https:\/\/doi.org\/10.1038\/onc.2014.136 (2015).","journal-title":"Oncogene"},{"key":"31069_CR5","first-page":"3000","volume":"47","author":"AM Fichtinger-Schepman","year":"1987","unstructured":"Fichtinger-Schepman, A. M., van Oosterom, A. T., Lohman, P. H. & Berends, F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res 47, 3000\u20133004 (1987).","journal-title":"Cancer Res"},{"issue":"24","key":"31069_CR6","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.15252\/embj.201592409","volume":"34","author":"R Planells\u2010Cases","year":"2015","unstructured":"Planells\u2010Cases, R. et al. Subunit Composition of VRAC Channels Determines Substrate Specificity and Cellular Resistance to Pt\u2010based Anti\u2010cancer Drugs. The EMBO Journal 34(24), 2993\u20133008, https:\/\/doi.org\/10.15252\/embj.201592409 (2015).","journal-title":"The EMBO Journal"},{"issue":"4","key":"31069_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.bjc.6606071","volume":"104","author":"M Yamasaki","year":"2011","unstructured":"Yamasaki, M. et al. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma. British Journal of Cancer. 104(4), 707\u2013713, https:\/\/doi.org\/10.1038\/sj.bjc.6606071 (2011).","journal-title":"British Journal of Cancer."},{"key":"31069_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jconrel.2015.07.015","volume":"215","author":"GH Lee","year":"2015","unstructured":"Lee, G. H. et al. Inhibition of cisplatin-resistance by RNA interference targeting metalllothionein using reducible oligo-peptoplex. J Control Release. 215, 82\u201390, https:\/\/doi.org\/10.1016\/j.jconrel.2015.07.015 (2015).","journal-title":"J Control Release."},{"key":"31069_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SA Morad","year":"2013","unstructured":"Morad, S. A. & Cabot, M. C. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13, 51\u201365, https:\/\/doi.org\/10.1038\/nrc3398 (2013).","journal-title":"Nat Rev Cancer"},{"issue":"49","key":"31069_CR10","doi-asserted-by":"publisher","first-page":"85759","DOI":"10.18632\/oncotarget.20482","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer. Oncotarget 8(49), 85759\u201385771, https:\/\/doi.org\/10.18632\/oncotarget.20482 (2017).","journal-title":"Oncotarget"},{"key":"31069_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzi","year":"2012","unstructured":"Galluzi, L. et al. Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869\u20131883, https:\/\/doi.org\/10.1038\/onc.2011.384 (2012).","journal-title":"Oncogene"},{"key":"31069_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-4615-2632-2_11","volume":"73","author":"PA Andrews","year":"1994","unstructured":"Andrews, P. A. Mechanisms of acquired resistance to cisplatin. Cancer Treat Res 73, 217\u2013248 (1994).","journal-title":"Cancer Treat Res"},{"key":"31069_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrd2355","volume":"6","author":"E Iorns","year":"2007","unstructured":"Iorns, E., Lord, C. J., Turner, N. & Ashworth, A. Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 6, 556\u2013568, https:\/\/doi.org\/10.1038\/nrd2355 (2007).","journal-title":"Nat Rev Drug Discov"},{"key":"31069_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1097-2765(03)00348-4","volume":"12","author":"P Aza-Blanc","year":"2003","unstructured":"Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 12, 627\u2013637 (2003).","journal-title":"Mol Cell"},{"key":"31069_CR15","doi-asserted-by":"publisher","first-page":"14819","DOI":"10.1073\/pnas.0604320103","volume":"103","author":"M Mukherji","year":"2006","unstructured":"Mukherji, M. et al. Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci USA 103, 14819\u201314824, https:\/\/doi.org\/10.1073\/pnas.0604320103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31069_CR16","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.1121119109","volume":"109","author":"M Toyoshima","year":"2012","unstructured":"Toyoshima, M. et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci USA 109, 9545\u20139550, https:\/\/doi.org\/10.1073\/pnas.1121119109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31069_CR17","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/onc.2012.416","volume":"32","author":"F Salm","year":"2013","unstructured":"Salm, F. et al. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. Oncogene 32, 3944\u20133953, https:\/\/doi.org\/10.1038\/onc.2012.416 (2013).","journal-title":"Oncogene"},{"key":"31069_CR18","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1158\/0008-5472.CAN-09-1178","volume":"69","author":"W Sakai","year":"2009","unstructured":"Sakai, W. et al. Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma. Cancer Res 69, 6381\u20136386, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1178 (2009).","journal-title":"Cancer Res"},{"key":"31069_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/35094000","volume":"1","author":"EC Friedberg","year":"2001","unstructured":"Friedberg, E. C. How nucleotide excision repair protects against cancer. Nat Rev Cancer 1, 22\u201333, https:\/\/doi.org\/10.1038\/35094000 (2001).","journal-title":"Nat Rev Cancer"},{"key":"31069_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature01408","volume":"421","author":"EC Friedberg","year":"2003","unstructured":"Friedberg, E. C. DNA damage and repair. Nature 421, 436\u2013440, https:\/\/doi.org\/10.1038\/nature01408 (2003).","journal-title":"Nature"},{"key":"31069_CR21","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.7150\/ijbs.13444","volume":"11","author":"M Li","year":"2015","unstructured":"Li, M. et al. Kruppel-Like Factor 5 Promotes Epithelial Proliferation and DNA Damage Repair in the Intestine of Irradiated Mice. Int J Biol Sci 11, 1458\u20131468, https:\/\/doi.org\/10.7150\/ijbs.13444 (2015).","journal-title":"Int J Biol Sci"},{"key":"31069_CR22","doi-asserted-by":"publisher","first-page":"31991","DOI":"10.1074\/jbc.M803612200","volume":"283","author":"JX Du","year":"2008","unstructured":"Du, J. X., Bialkowska, A. B., McConnell, B. B. & Yang, V. W. SUMOylation regulates nuclear localization of Kruppel-like factor 5. J Biol Chem 283, 31991\u201332002, https:\/\/doi.org\/10.1074\/jbc.M803612200 (2008).","journal-title":"J Biol Chem"},{"key":"31069_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nm1756","volume":"14","author":"Y Oishi","year":"2008","unstructured":"Oishi, Y. et al. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. Nat Med 14, 656\u2013666, https:\/\/doi.org\/10.1038\/nm1756 (2008).","journal-title":"Nat Med"},{"key":"31069_CR24","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1242\/dev.126.20.4569","volume":"126","author":"MC Puri","year":"1999","unstructured":"Puri, M. C., Partanen, J., Rossant, J. & Bernstein, A. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126, 4569\u20134580 (1999).","journal-title":"Development"},{"key":"31069_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato, T. N. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70\u201374, https:\/\/doi.org\/10.1038\/376070a0 (1995).","journal-title":"Nature"},{"key":"31069_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1083\/jcb.200411105","volume":"169","author":"P Saharinen","year":"2005","unstructured":"Saharinen, P. et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 169, 239\u2013243, https:\/\/doi.org\/10.1083\/jcb.200411105 (2005).","journal-title":"J Cell Biol"},{"key":"31069_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang, H., Bhat, A., Woodnutt, G. & Lappe, R. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 10, 575\u2013585, https:\/\/doi.org\/10.1038\/nrc2894 (2010).","journal-title":"Nat Rev Cancer"},{"key":"31069_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ccr.2004.09.030","volume":"6","author":"J Oliner","year":"2004","unstructured":"Oliner, J. et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6, 507\u2013516, https:\/\/doi.org\/10.1016\/j.ccr.2004.09.030 (2004).","journal-title":"Cancer Cell"},{"key":"31069_CR29","first-page":"1745","volume":"5","author":"WC Lin","year":"1999","unstructured":"Lin, W. C. et al. tie-1 Protein Tyrosine Kinase: A Novel Independent Prognostic Marker for Gastric Cancer. Clinical Cancer Research 5, 1745\u20131751 (1999).","journal-title":"Clinical Cancer Research"},{"key":"31069_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3748\/wjg.v11.i7.964","volume":"11","author":"T Nakayama","year":"2005","unstructured":"Nakayama, T. et al. Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors. World Journal of Gastroenterology: WJG 11, 964\u2013969, https:\/\/doi.org\/10.3748\/wjg.v11.i7.964 (2005).","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"31069_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ijc.2910540409","volume":"54","author":"WG Cance","year":"1993","unstructured":"Cance, W. G., Craven, R. J., Weiner, T. M. & Liu, E. T. Novel protein kinases expressed in human breast cancer. Int J Cancer 54, 571\u2013577 (1993).","journal-title":"Int J Cancer"},{"key":"31069_CR32","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/MCB.22.6.1704-1713.2002","volume":"22","author":"CD Kontos","year":"2002","unstructured":"Kontos, C. D., Cha, E. H., York, J. D. & Peters, K. G. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 22, 1704\u20131713 (2002).","journal-title":"Mol Cell Biol"},{"key":"31069_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/cbt.8.1.7209","volume":"8","author":"IKRA Kolasa","year":"2009","unstructured":"Kolasa, I. K. R. A. et al. PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients. Cancer Biol Ther 8, 21\u201326 (2009).","journal-title":"Cancer Biol Ther"},{"key":"31069_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2004.11.051","volume":"97","author":"S Lee","year":"2005","unstructured":"Lee, S., Choi, E.-J., Jin, C. & Kim, D.-H. Activation of PI3K\/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol 97, 26\u201334 (2005).","journal-title":"Gynecol Oncol"},{"key":"31069_CR35","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/nar\/gkg310","volume":"31","author":"Z Zhang","year":"2003","unstructured":"Zhang, Z. & Teng, C. T. Phosphorylation of Kruppel-like factor 5 (KLF5\/IKLF) at the CBP interaction region enhances its transactivation function. Nucleic Acids Res 31, 2196\u20132208 (2003).","journal-title":"Nucleic Acids Res"},{"key":"31069_CR36","first-page":"414","volume":"47","author":"BC Behrens","year":"1987","unstructured":"Behrens, B. C. et al. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47, 414\u2013418 (1987).","journal-title":"Cancer Res"},{"key":"31069_CR37","first-page":"4970","volume":"45","author":"J Benard","year":"1985","unstructured":"Benard, J. et al. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 45, 4970\u20134979 (1985).","journal-title":"Cancer Res"},{"key":"31069_CR38","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","volume":"89","author":"AK Godwin","year":"1992","unstructured":"Godwin, A. K. et al. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89, 3070\u20133074 (1992).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31069_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","volume":"36","author":"DM Provencher","year":"2000","unstructured":"Provencher, D. M. et al. Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 36, 357\u2013361, https:\/\/doi.org\/10.1290\/1071-2690 (2000).","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"31069_CR40","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1038\/onc.2015.425","volume":"35","author":"S Shigeta","year":"2016","unstructured":"Shigeta, S. et al. Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer. Oncogene 35, 3577\u20133586, https:\/\/doi.org\/10.1038\/onc.2015.425 (2016).","journal-title":"Oncogene"},{"key":"31069_CR41","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/onc.2015.330","volume":"35","author":"K Kitatani","year":"2016","unstructured":"Kitatani, K. et al. Ceramide limits phosphatidylinositol-3-kinase C2beta-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene 35, 2801\u20132812, https:\/\/doi.org\/10.1038\/onc.2015.330 (2016).","journal-title":"Oncogene"},{"key":"31069_CR42","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","volume":"17","author":"E Schreiber","year":"1989","unstructured":"Schreiber, E., Matthias, P., Muller, M. M. & Schaffner, W. Rapid detection of octamer binding proteins with \u2018mini-extracts\u2019, prepared from a small number of cells. Nucleic Acids Res 17, 6419 (1989).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31069-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:10:49Z","timestamp":1671613849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31069"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31069-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"23 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13207"}}